News
Jubilant Wins $146.6 Mn Contract To Boost Injectables Output
Jubilant HollisterStier has grabbed a $146.6 million contract from the US government, continuing to ride the industrial expansion wave created by the COVID-19 business boom. The contract, which was signed with numerous agencies of the Department of Health and...
News
Sandoz Endorses A Global Campaign To Promote Biosimilars
Sandoz, a biosimilars manufacturer, has announced the beginning of a new global campaign to combat global health disparities. By harnessing the '4 As' of biosimilars- approval, accessibility, acceptability, and affordability, Act4Biosimilars strives to expand patient access to innovative treatments....
News
UK Is First Country Passing Pandemic Preparedness Resolution
After the United Kingdom and Argentina presented a "landmark" decision to the World Health Assembly in Geneva recently, the world took a huge step toward greater pandemic preparedness.
More specific financing will be advocated for within the resolution, allowing developing...
News
The FDA Approves Novartis Follicular Lymphoma Cell Therapy
The US Food and Drug Administration (FDA) has granted Novartis expedited approval for its CAR-T cell therapy Kymriah (tisagenlecleucel) to treat people with relapsed or refractory (r/r) follicular lymphoma (FL) following two or more lines of conventional therapy.
As part...
News
NRG Gets A Boost of £2.68 Mn For Neurodegenerative Diseases
NRG Therapeutics, a neuroscience firm, has been presented with the Biomedical Catalyst award. The £2.68 million package will be used to advance the pre-clinical development of the company's innovative small molecule disease-modifying medicines for the treatment of Parkinson's disease,...
News
MoU Inked By The UK And Sweden To Engage In Lifesciences
The United Kingdom and Sweden have reached a deal through an MoU recognising their existing bilateral collaboration in the biological sciences. The goal of the MoU is to foster collaboration among participants in the health, research, as well as innovation systems...
News
Scientists Find A Possible Antiviral Treatment For Monkeypox
Scientists have discovered a viable antiviral therapy for monkeypox, albeit the illness remains a considerably less serious threat than COVID, according to the researchers. As per new research on historical outbreaks of monkeypox in the UK, a patient seemed...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.